Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 156

Results For "research"

2124 News Found

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


Bar Ilan University launches course on 3D printing in medicine
News | March 25, 2022

Bar Ilan University launches course on 3D printing in medicine

A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs


BSV standardises on Veeva Vault PromoMats to speed content distribution
Digitisation | March 25, 2022

BSV standardises on Veeva Vault PromoMats to speed content distribution

Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials


Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma
Drug Approval | March 25, 2022

Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma

This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


SRL Diagnostics launches whole genome sequencing test for Tuberculosis
Diagnostic Center | March 24, 2022

SRL Diagnostics launches whole genome sequencing test for Tuberculosis

The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate
Drug Approval | March 24, 2022

Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate

The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age


Totus Medicines partners with Mila on a mission to treat the untreatable
Biotech | March 24, 2022

Totus Medicines partners with Mila on a mission to treat the untreatable

Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale


Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate
Biotech | March 23, 2022

Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate

Data to establish the safety profile and human dose of vaccine candidate